May 24, 2022

The Globe and Mail | Chinook Therapeutics shares rise on promising results for kidney disease drugs from B.C. company

Antonia Borovina, Bloom Burton Equity Research Analyst comments on the latest news from Chinook Therapeutics Inc. (NASDAQ: KDNY) on IgA nephropathy.

Click here to read the full article.